| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |